CAMARDA, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 3.153
EU - Europa 714
AS - Asia 600
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 4.488
Nazione #
US - Stati Uniti d'America 3.134
CN - Cina 282
UA - Ucraina 167
SG - Singapore 161
DE - Germania 154
IT - Italia 118
TR - Turchia 116
GB - Regno Unito 112
FI - Finlandia 68
SE - Svezia 46
VN - Vietnam 27
CA - Canada 19
BR - Brasile 13
BE - Belgio 11
NL - Olanda 11
FR - Francia 9
LT - Lituania 5
RU - Federazione Russa 4
AR - Argentina 3
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
ID - Indonesia 2
IR - Iran 2
PL - Polonia 2
AU - Australia 1
BG - Bulgaria 1
EC - Ecuador 1
IE - Irlanda 1
IQ - Iraq 1
KW - Kuwait 1
LU - Lussemburgo 1
NP - Nepal 1
ZA - Sudafrica 1
Totale 4.488
Città #
Fairfield 475
Woodbridge 431
Houston 245
Jacksonville 188
Ashburn 186
Seattle 175
Chandler 173
Cambridge 161
Ann Arbor 139
Wilmington 136
Singapore 125
Santa Clara 124
Nanjing 64
Izmir 62
Beijing 51
San Diego 47
New York 44
Milan 40
Princeton 40
Boardman 33
Helsinki 32
Shanghai 32
Munich 31
Dong Ket 26
Dearborn 22
Ferrara 21
Bremen 20
Addison 16
Hebei 16
Mcallen 16
Shenyang 16
Nanchang 13
Auburn Hills 12
Montréal 12
Brussels 11
London 11
Changsha 10
Norwalk 9
Philadelphia 9
Los Angeles 8
Falkenstein 7
Jiaxing 7
Jinan 7
Ningbo 7
Padova 7
Tianjin 7
Mountain View 6
Falls Church 5
Indiana 5
Tappahannock 5
Amsterdam 4
Bologna 4
Frankfurt am Main 4
Guangzhou 4
Redwood City 4
San Mateo 4
Toronto 4
Kunming 3
Orange 3
Redmond 3
Rome 3
Taizhou 3
Verona 3
Zhengzhou 3
Acton 2
Augusta 2
Aurora 2
Des Moines 2
Hefei 2
Hounslow 2
Jakarta 2
Lanzhou 2
Lodz 2
Messina 2
Monmouth Junction 2
Ottawa 2
Prescot 2
San Francisco 2
Scorzè 2
São Paulo 2
Vienna 2
Wandsworth 2
Washington 2
Ardabil 1
Baghdad 1
Belford Roxo 1
Boston 1
Brasópolis 1
Brno 1
Buffalo 1
Charlotte 1
Chicago 1
Chiswick 1
Collecorvino 1
Colleferro 1
College Station 1
Dhaka 1
Dublin 1
Düsseldorf 1
Espoo 1
Totale 3.449
Nome #
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 247
null 205
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 155
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 149
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 146
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 140
A new ligand for the urotensin II receptor 138
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 133
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 128
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 124
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 122
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 121
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 120
Structure-activity study at positions 3 and 4 of human neuropeptide S. 120
Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle 117
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 116
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 116
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 115
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 115
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 113
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 113
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems 112
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 112
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 111
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 111
Pharmacological characterisation of novel kinin B2 receptor ligands 109
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 105
Structure-activity relationship study on human urotensin II 104
Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors 102
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 100
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. 98
null 94
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 91
null 87
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 83
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 79
null 78
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 38
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 33
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 23
Totale 4.523
Categoria #
all - tutte 21.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 681
Totale 21.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020254 0 0 0 0 0 0 0 0 86 94 51 23
2020/2021580 48 62 26 91 23 50 31 62 13 59 61 54
2021/2022456 17 52 54 5 31 14 31 26 13 41 41 131
2022/2023439 43 26 15 51 79 59 34 35 56 1 21 19
2023/2024266 21 32 15 8 8 59 11 21 3 4 16 68
2024/2025452 35 27 105 23 108 92 23 36 3 0 0 0
Totale 4.523